3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
11
Terminated
10
Recruiting
8
Unknown
4
Active not recruiting
3
Withdrawn
2
Not yet recruiting
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
240
Carcinoma, Renal Cell
75
Urinary Bladder Neoplasms
56
Kidney Neoplasms
32
Breast Neoplasms
26
Neoplasms
25
Carcinoma, Transitional Cell
22
Neoplasm Metastasis
21
Carcinoma, Non-Small-Cell Lung
14
Sarcoma
11
Non-Muscle Invasive Bladder Neoplasms
11
Lung Neoplasms
11
Melanoma
10
Wilms Tumor
8
Testicular Neoplasms
8
Colorectal Neoplasms
8
Uterine Cervical Neoplasms
7
Urologic Neoplasms
7
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Small Cell Lung Carcinoma
6
Recurrence
6
Ovarian Neoplasms
6
Endometrial Neoplasms
6
Carcinoma, Hepatocellular
6
Carcinoma
6
Prostatic Neoplasms, Castration-Resistant
5
Neuroblastoma
5
Esophageal Neoplasms
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
Urologic Diseases
×
Genitourinary
×
Clear all
NCT01799499
2015-09-01
NMIBC TURBT HG
UroGen Pharma Ltd.
Phase NA
Withdrawn
NCT02254915
2015-04-01
SHTC-EUROPE-1
Medical Enterprises Europe B.V.
Phase 3
Withdrawn